Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of δ-opiate receptors during diabetes mellitus

Bulletin of Experimental Biology and Medicine

Volumn 137, Issue 2, 2004, Pages 147-149

  Agadjanov, M I ^a   Vartanian, G S ^a   Tadevosyan, Yu V ^b   Batikyan, T B ^b   Agadjanova, E M ^a  

^a YEREVAN STATE MEDICAL UNIVERSITY   (Armenia)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

Author keywords

Diabetes; Lymphocytes; Nociception; Opiate receptor agonists and antagonists; Phosphoinositides

Indexed keywords

7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; NALTRIBEN; PHOSPHATIDYLINOSITIDE; RECEPTOR SUBTYPE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; RECEPTOR SENSITIVITY; SIGNAL TRANSDUCTION;

BENZYLIDENE COMPOUNDS; DIABETES MELLITUS; DIGLYCERIDES; HUMANS; LYMPHOCYTES; NALTREXONE; OLIGOPEPTIDES; PHOSPHATIDYLINOSITOLS; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION;

EID: 4344586952     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BEBM.0000028125.22568.aa     Document Type: Article

References (12)

1. G. S. Vartanian, M. I. Agadjanov, Yu. V. Tadevosyan, and T. B. Batikyan, Byull. Eksp. Biol. Med., 122, No. 10, 405-407 (1996).
2. N. V. Prokazina, N. D. Zvezdina, and A. A. Korotaeva, Biokhimiya, 63, No. 1, 38-46 (1998).
3. Yu. V. Tadevosyan, L. Yu. Asatryan, T. B. Batikyan, and K. G. Karagezyan, Ibid., 61, No. 8, 1414-1421 (1996).
4. M. I. Agadjanov and G. S. Vartanian, Neurochemistry. Cellular, Molecular, and Clinical Aspects, New York, London (1997), pp. 1019-1023.
5. E. G. Bligh and W. I. Dyer, Can. J. Med. Sci., 37, No. 8, 911-917 (1959).
6. H. Hakamata, T. Sasaki, S. Yui, et al., J. Biol. Chem., 269, 31,430-31,435 (1998).
7. J. B. Innes, M. M. Kuntz, Y. T. Kim, and M. E. Weksler, J. Clin. Invest., 64, No. 6, 1608-1613 (1979).
8. J. Kamei, M. Sodeyama, M. Ohsawa, et al., Life Sci., 62, No. 1, PL1-PL6 (1998).
9. M. Ohsawa, H. Nagase, and J. Kamei, J. Pharmacol. Exp. Ther., 286, No. 2, 780-787 (1998).
10. T. Sir-Petermann, G. Lopez, and T. Castillo, Exp. Clin. Endocrinol. Diabetes, 106, No. 5, 389-394 (1998).
11. M. Tandon, R. K. Srivastava, R. K. Nagpal, et al., Eur. J. Pharmacol., 399, Nos. 2-3, 161-164 (2000).
12. J. R. Zurek, R. Nadeson, and C. S. J. Goodchild, Diabetes Complications, 14, No. 2, 65-70 (2000).